Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence: A Placebo-Controlled Trial

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neuropsychopharmacology

• Publication date

  2000-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0893-133X(99)00135-9PMID 10731624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence

  2005cited by this paper
• Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects.

  2000cited by this paper
• Effects of naltrexone on alcohol self-administration in heavy drinkers.

  1999cited by this paper
• A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

  1999cited by this paper
• Nefazodone attenuates the behavioral and neurochemical effects of ethanol.

  1998cited by this paper
• Sustained-release naltrexone for alcoholism treatment: a preliminary study.

  1998influential reference
• Advances in development of medications for alcoholism treatment

  1998influential reference
• Naltrexone treatment of comorbid alcohol and cocaine use disorders

  1998cited by this paper
• The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.

  1997influential reference
• Naltrexone and alcohol dependence. Role of subject compliance.

  1997cited by this paper
• Naltrexone as an adjunctive treatment for older patients with alcohol dependence.

  1997cited by this paper
• Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism.

  1996cited by this paper
• A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.

  1996cited by this paper
• Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

  1996influential reference
• Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.

  1995cited by this paper
• The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior.

  1995cited by this paper
• Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

  1995cited by this paper
• Fluoxetine attenuates alcohol intake and desire to drink

  1994cited by this paper
• Naltrexone and the Treatment of Alcohol Dependence

  1994influential reference
• Naltrexone-induced alterations in human ethanol intoxication.

  1994cited by this paper
• 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.

  1993cited by this paper
• Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism.

  1993cited by this paper
• Effects of fluoxetine and ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcoholic patients

  1992cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1992cited by this paper
• Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.

  1992cited by this paper
• The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

  1992cited by this paper
• Naltrexone and coping skills therapy for alcohol dependence. A controlled study.

  1992cited by this paper
• Effect of fluoxetine on alcohol consumption in male alcoholics.

  1992cited by this paper
• Ritanserin Reduces Abuse of Alcohol, Cocaine, and Fentanyl in Rats

  1991cited by this paper
• Plasma β-endorphin levels in chronic alcoholics

  1990cited by this paper
• Plasma beta-endorphin levels in chronic alcoholics.

  1990cited by this paper
• Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers

  1990cited by this paper
• Serotonin uptake blockers and the treatment of alcoholism.

  1989cited by this paper
• Differential effects of viqualine on alcohol intake and other consummatory behaviors

  1989cited by this paper
• Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism.

  1989cited by this paper
• Statistical Power Analysis for the Behavioral Sciences (2nd ed.)

  1989cited by this paper
• The serotonin uptake inhibitor citalopram attenuates ethanol intake

  1987cited by this paper
• The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research.

  1986cited by this paper
• SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

  1986cited by this paper
• Naltrexone-induced dysphoria in former opioid addicts.

  1985cited by this paper
• Zimelidine‐induced variations in alcohol intake by nondepressed heavy drinkers

  1984cited by this paper
• "Never believe an alcoholic"? On the validity of self-report measures of alcohol dependence and related constructs.

  1983cited by this paper
• Central Deficiency of β-Endorphin in Alcohol Addicts

  1982cited by this paper
• Central deficiency of beta-endorphin in alcohol addicts.

  1982cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 3rd ed

  1981cited by this paper
• Developing a Prototype for Evaluating Alcohol Treatment Effectiveness

  1980cited by this paper
• Reliability of alcohol abusers' self-reports of drinking behavior.

  1979cited by this paper
• Effects of naltrexone on mood and neuroendocrine function in normal adult males.

  1978cited by this paper
• The Michigan alcoholism screening test: the quest for a new diagnostic instrument.

  1971influential reference
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• Tests of certain linear hypotheses and their application to some educational problems.

  1936cited by this paper

• Galanin(1-15) and Naltrexone: A novel approach for alcohol use disorder in rats, involving the mesolimbic system.

  2025cites this paper
• The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature

  2024influential citation
• Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis.

  2024cites this paper
• Introduction: Approved treatments for alcohol use disorder by regulatory agencies.

  2024cites this paper
• EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY.

  2024cites this paper
• Antagonists of the stress and opioid systems restore the functional connectivity of the prefrontal cortex during alcohol withdrawal through divergent mechanisms

  2023cites this paper
• Integrative Pharmacology in the Treatment of Substance Use Disorders

  2023cites this paper
• A Patient with Alcoholic Liver Disease Reports for Treatment of Dentoalveolar Abscess in Relation to Maxillary Left Molar.

  2023cites this paper
• Pharmacogenetics of Addiction Therapy.

  2022cites this paper
• Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

  2022cites this paper
• The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review

  2022cites this paper
• A Call to Action: A Systematic Review Examining the Failure to Include Females and Members of Minoritized Racial/Ethnic Groups in Clinical Trials of Pharmacological Treatments for Alcohol Use Disorder.

  2020cites this paper
• Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity.

  2020influential citation
• Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis

  2019cites this paper
• Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis

  2019cites this paper
• Dual Therapy for Alcohol Use Disorders: Combining Naltrexone With Other Medications

  2019cites this paper
• State-of-the-Art Treatment of Alcohol Use Disorder

  2019cites this paper
• Alcoholism and its implications for the dental team, an update and review of the literature

  2019cites this paper
• Novel molecular targets for treating alcohol use disorder and hepatotoxicity

  2019cites this paper
• Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

  2018cites this paper
• Pharmacological and Psychological Treatments for Comorbid Alcohol Use Disorder and Depressive Disorder: a Review

  2018cites this paper
• Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review

  2018cites this paper
• Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate

  2018cites this paper
• Association between alcoholic interventions and abstinence rates for alcohol use disorders

  2018cites this paper
• Compounds Including Cox Inhibitor Moiety and Enhanced Delivery of Active Drugs Using Same

  2018cites this paper
• State-of-the-art behavioral and pharmacological treatments for alcohol use disorder

  2018cites this paper
• Alcohol Stimulation and Sedation: a Critical Review of the Biphasic Alcohol Effects Scale

  2017cites this paper
• Evaluation of a Predictive Algorithm that Detects Aberrant Use of Opioids in anAddiction Treatment Centre

  2017cites this paper
• Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder

  2017cites this paper
• Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence

  2016cites this paper
• Opioid Receptor Agonists and Antagonists

  2016cites this paper
• Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.

  2016cites this paper
• Functional imaging of neural systems associated with alcohol reward and amphetamine toxicity

  2016cites this paper
• Kappa‐opioid receptors differentially regulate low and high levels of ethanol intake in female mice

  2016cites this paper
• Evaluation in alcohol use disorders – insights from the nalmefene experience

  2016cites this paper
• Pharmacological treatments for alcohol dependence 1 SAFETY AND TOLERABILITY OF PHARMACOLOGICAL TREATMENT OF ALCOHOL DEPENDENCE : COMPREHENSIVE REVIEW OF EVIDENCE

  2016cites this paper
• Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis

  2016cites this paper
• Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking.

  2016cites this paper
• Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme

  2015cites this paper
• Substance‐Related Disorders: Alcohol‐Related Disorders

  2015cites this paper
• Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers

  2015cites this paper
• The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.

  2015cites this paper
• Los Antagonistas de los Receptores Opioides en el Tratamiento del Alcoholismo

  2015cites this paper
• Randomized Controlled Trial of a Mobile Phone Intervention for Improving Adherence to Naltrexone for Alcohol Use Disorders

  2015cites this paper
• Opioid Receptor Antagonists in the Treatment of Alcoholism.

  2015cites this paper
• Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers

  2015cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone

  2014cites this paper
• Prodrug Strategies for Enhancing the Percutaneous Absorption of Drugs

  2014cites this paper
• Pharmacogenetics of addiction therapy.

  2014cites this paper
• The role of the opioid system in alcohol dependence

  2014cites this paper
• Efficacy and safety of the glycine transporter-1 inhibitor org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial.

  2014cites this paper
• Predictors of Self-Reported Adherence to Naltrexone Medication in an Outpatient Treatment for Problem Drinking

  2013cites this paper
• An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol

  2013cites this paper
• Placebo Group Improvement in Trials of Pharmacotherapies for Alcohol Use Disorders: A Multivariate Meta-Analysis Examining Change Over Time

  2013cites this paper
• Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

  2013cites this paper
• New therapeutic approaches in alcohol dependence: reduction of consumption as a step in the therapeutic goal Nuovi approcci terapeutici nei disturbi correlati all'uso di alcol: la riduzione del consumo come step terapeutico

  2013cites this paper
• The μ-opioid receptor and treatment response to naltrexone.

  2013cites this paper
• The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.

  2013cites this paper
• How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?

  2013cites this paper
• Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.

  2012cites this paper
• Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study

  2012cites this paper
• Association of µ‐opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta‐analysis

  2012cites this paper
• Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysis.

  2012cites this paper
• Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.

  2012cites this paper
• Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs

  2011cites this paper
• Cambio de paradigma en el tratamiento del alcoholismo de baja gravedad A change of paradigm in the tretment of low-severity alcohol- dependent patients

  2011cites this paper
• Medical Treatment of Alcohol Dependence: A Systematic Review

  2011influential citation
• A change of paradigm in the treatment of low-severity alcohol-dependent patients.

  2011cites this paper
• MICRONEEDLE-ASSISTED TRANSDERMAL DELIVERY OF NALTREXONE SPECIES: IN VITRO PERMEATION AND IN VIVO PHARMACOKINETIC STUDIES

  2011cites this paper
• Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.

  2010cites this paper
• Opioid antagonists for alcohol dependence.

  2010cites this paper
• Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients (IMPACT): Design and Implementation

  2010cites this paper
• Nalmefene for treatment of alcohol dependence

  2010cites this paper
• Addictive Disorders in Psychiatric Medicine

  2010cites this paper
• Opioid antagonists for alcohol dependence.

  2010cites this paper
• Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.

  2010cites this paper
• Alcohol Measures for Public Health Research Alliance (AMPHORA)

  2010cites this paper
• Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

  2010cites this paper
• The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study

  2010influential citation
• Medications acting on the serotonergic system for the treatment of alcohol dependent patients.

  2010cites this paper
• Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature.

  2010cites this paper
• Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence.

  2009cites this paper
• Extended naltrexone and broad spectrum treatment or motivational enhancement therapy

  2009influential citation
• A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

  2009cites this paper
• Effects of naltrexone on cortisol levels in heavy drinkers.

  2009cites this paper
• Pharmacotherapeutic Effects of Opioid Antagonists in Alcohol-Abusing Patients with Schizophrenia

  2009cites this paper
• Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

  2009cites this paper
• Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol.

  2009cites this paper
• Development of Opioid Transdermal Delivery Systems

  2009cites this paper
• The Chemistry and Pharmacology of Delta Opioid Antagonists

  2009cites this paper
• Incorporating Alcohol Pharmacotherapies Into Medical Practice : A Review of the Literature — Updates * A Treatment Improvement Protocol TIP 49

  2009cites this paper
• Endogenous opioids and addiction to alcohol and other drugs of abuse.

  2009cites this paper
• A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.

  2008cites this paper
• Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study.

  2008cites this paper
• A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

  2008cites this paper
• In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.

  2008cites this paper
• Medikamente zur Behandlung von Abhängigkeit und Entzugssymptomen

  2008cites this paper
• Effects of naltrexone during the descending limb of the blood alcohol curve.

  2008cites this paper
• Pharmakologische Therapieoptionen zur Prävention des Alkoholrückfalls

  2008cites this paper